4//SEC Filing
Nieman Richard 4
Accession 0000899243-22-025968
CIK 0001327273other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:10 PM ET
Size
5.7 KB
Accession
0000899243-22-025968
Insider Transaction Report
Form 4
Nieman Richard
Chief Medical Officer
Transactions
- Award
Stock Option
2022-07-11+230,000→ 230,000 totalExercise: $6.08Exp: 2032-07-10→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 25% of the underlying shares on July 11, 2023 and in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001936888
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:10 PM ET
- Size
- 5.7 KB